ACOG CONFLICT OF INTEREST POLICY FOR EXECUTIVE BOARD MEMBERS, COMMITTEE CHAIRS, TASK FORCE CHAIRS, AND EXECUTIVE STAFF All ACOG* Executive Board Members, committee chairs, task force chairs and executive staff (each a “Covered Individual”) are required to follow guidelines for relationships with the health care industry as contained in the American College of Obstetricians and Gynecologists’ Committee Opinion #541, Professional Relationships With Industry, November 2012, which may be revised from time to time. Covered Individuals also must adhere to the following policy: A Covered Individual and a Covered Individual’s spouse or domestic partner shall not: •Have a financial interest in excess of $5,000, except in a blind trust, exchange tradedfunds or through mutual fund investments, in an individual pharmaceutical company oran individual manufacturer of medical instruments, devices or equipment •Receive any consulting fees, royalties, honoraria, in-kind services, or payments of anykind for their personal use from a pharmaceutical company or a manufacturer ofmedical instruments, devices or equipment, except for payments in relation to clinicalinvestigations or studies conducted in accordance with federal requirements •Accept anything of value in excess of $50 at one time, with a maximum annual limit of$250 for their personal use from a single pharmaceutical company or a manufacturerof medical instruments, devices or equipment, except for items in relation to clinicalinvestigations or studies conducted in accordance with federal requirements •Be on a speakers bureau of a pharmaceutical company or a manufacturer of medicalinstruments, devices or equipment •Have a consulting or advisory arrangement with a pharmaceutical company or amanufacturer of medical instruments, devices or equipment, except in relation toclinical investigations or studies conducted in accordance with federal requirements •Serve on a corporate board of a pharmaceutical company or a manufacturer of medicalinstruments, devices or equipment A Covered Individual shall have a continuing responsibility to comply with this policy. If a Covered Individual ceases to be compliant with this policy, the Covered Individual shall inform the President and Executive Vice President and CEO immediately. *This policy has been approved by the Executive Boards of the American College of Obstetricians and Gynecologists and the American Congress of Obstetricians and Gynecologists, August 2015. The College and the Congress are referred to collectively in this policy as ACOG.

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998